Allied Minds plc
ALLWF
Other OTC0.10
USD
+0.10
- -
ISIN
GB00BLRLH124
Return %
Stock
S&P500
1Y
99,900.00
26.53
3Y
-57.45
76.60
5Y
-78.26
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Nina C. Thayer
- Full Time Employees
- 21
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 374 Congress Street Boston MA United States of America 02210
- IPO Date
- Apr 13, 2015
- Website
- alliedminds.com
- Similar Companies
- Business
- Allied Minds plc (ALLWF) is a Boston-based IP commercialization company founded in 2006 that focuses on early-stage development and funding of technology and life sciences ventures sourced from US federal laboratories, universities, and corporations; it manages a portfolio of companies commercializing disruptive innovations in connectivity, space, medical devices, semiconductors, cyber security, communications, big data, diagnostics, biopharmaceuticals, and food safety. The firm provides operational support including business strategy, sales, marketing, finance, legal, and transaction execution to portfolio entities such as Federated Wireless, which delivers shared spectrum solutions for network operators; BridgeComm, advancing laser communications; Orbital Sidekick, specializing in space-based hyperspectral imagery and analytics; and OcuTerra Therapeutics, developing ophthalmic therapies like OTT166 for retinal diseases. Primarily operating in the United States with additional presence in London, Los Angeles, Seattle, New York, and Washington DC, Allied Minds targets pre-seed, seed, and Series A investments ranging from $0.25 million to $10 million per deal, seeking majority equity positions and partnering with co-investors like Cerberus Capital Management, GIC, Temasek, and Energy Innovation Capital. In recent developments, the company delisted from the London Stock Exchange in November 2022 following shareholder approval to reduce high listing costs relative to its portfolio value, enabling a managed monetization approach; portfolio milestones include Federated Wireless securing May 2022 funding at a $302 million valuation, Orbital Sidekick raising funds in March 2024 at $66.6 million post-money, OcuTerra Therapeutics completing a Series B for Phase II trials, and the full acquisition of TableUp by an undisclosed buyer.